<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Publication Alert: Q317 Wound Care Surgical Matrices Quarterly Market Recap

Posted by Doug Devens on 12/19/17 2:04 PM

Q317 US Surgical Matrices Market: Strong Growth Continues in Breast Matrices 

The US Surgical Matrices Market saw growth in Q317 as sales of allografts fueled double-digit growth in breast matrices and biosynthetics offset declines in biologics in hernia repair.

By Doug Devens, Senior Analyst Biosurgery

The US Surgical Matrices market, consisting of hernia repair and breast reconstruction products, continued uneven growth in Q317.  Allergan continued to capture share in the overall market, using its growth in allografts to increase its share.

Read More

Topics: Advanced Wound Care-Surgical Matrices

Innovation and Clinical Outcomes Shaping the Future of Hernia Repair

Posted by Susan Paquette on 7/17/17 5:47 PM

Continued Shift from Biologic to Synthetic Mesh

Innovation and clinical outcomes are shaping the future of the US ventral hernia market. Over the next several years, the market will see a continued shift from biologic mesh to synthetic mesh, growth in robotic hernia repairs, and an increased focus on clinical efficacy and economic outcomes data that will drive product adoption and impact market shares, particularly in the biosynthetic segment.

Read More

Topics: Advanced Wound Care-Surgical Matrices

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts